eNews
Home page > Comments


Comments

Celgene's Abraxane improved pancreatic cancer survival in trial

10.11.2012. | (Reuters) - Celgene Corp said on Friday that a clinical trial of Abraxane, its drug to treat breast and lung cancer, improved survival in patients with pancreatic cancer....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: